616 JOURNAL OF COSMETIC SCIENCE basis and completed a questionnaire with eight items addressing the cosmetic qualities of the product, and five items referring to its cosmetic efficacy. Likewise, skin tolerability was analyzed by a dermatologist and a pediatrician through visual inspection of the study zone. An ophthalmologist evaluated ocular acceptability by examining the ocular mucosa and periocular zone before and after 4 weeks of use. The results of the cosmetic and efficacy evaluations are detailed in Table III and Figures 2–4. Between 86.4 and 100% of the observing parents agreed with all the aspects referred to the cosmetic qualities of the product. On the other hand, the rating of efficacy was very satisfactory with agreement expressed by 88.9 to 100% of the observing parents. ANSWERS POSSIBLE QUESTIONS 1. I am concerned about scars of superficial wounds, irritations, and aggression of the skin. 2. I am concerned about post-peeling, post-depilation, and solar aggressions. 3. I have tried some type of treatment to help repair or strengthen my skin (soothing irritation, favoring skin regeneration, etc.). - Too much - Much - Neither much nor little - Little - None 4. If affirmative, I applied the treatment... - I bought the product but did not use it - 1 wk - 2 wk - 1 mo - More than 1 mo 5. The product has generally improved the appearance of my skin. 6. The product has a pleasant texture. 7. The product leaves my skin feeling soft and smooth. 8. The product hydrates my skin. 9. I consider that the product strengthens my skin. 10. The product has a pleasant smell. 11. The product is quickly absorbed. 12. The product leaves no residue on the skin. 13. The product is not oily. 14. The product does not stain clothing. 15. In general, I am satisfied with the product. 16. Would you recommend this product to your friends? - Very much agree - Agree - Neither agree nor disagree - Disagree - Very much disagree 17. How much would you pay for the tested product? - Less than 10€ - Between 10–15€ - Less than 20€ - Between 20–25€ 18. Considering the previous answer, would you buy the product if it cost 15€? - Yes, certainly - Probably - I don't know - No - Never 19. How often would you apply this product? - 3 times a week - Once a day in the morning - Once a day at night - Twice a day - Three times a day 20. Do you consider it adequate to have two presentations (50 and 150 mL) of the product according to its point / extensive use? 21. Do you consider this to be a unisex product? 22. Would you use it again? - Yes - No 23. Product format, 50 mand 150 mL we would like to know which format you would use in each case. - Post-healing - Irritation - Skin aggression - Sunburn - Post-peeling - Post-depilation - After shaving - Post-laser surgery - Tattoos Figure 1. Questionnaire used in the efficacy and acceptability study of Blastoactiva™ in healthy volunteers.
617 CENTELLA ASIATICA EXTRACTS IN SKIN REPAIR PRODUCTS In 11 children that presented skin irritation during the study on the face, untreated diaper zone, or rest of the body, the irritation disappeared in all cases after application of the product within 24 h in four children, 2–3 d in five children, and in over 3 d in the two remaining children. Furthermore, 10 parents (91%) of these children considered that the product favored skin repair, alleviated reddening, and repaired rubbing or friction (chafing) zones. These results are detailed in Table IV and Figure 5. Lastly, according to the clinical Table I Results Referring to the Anti-irritant, Skin Barrier Function Repair, and Epidermal Cell Renewal Effects of Blastoactiva™ Variable Forearm control Forearm treated Difference p valuea Intensity of erythema (anti-irritant) Colorimetry, % variation D2 versus D1 7 ± 28% 9 ± 32% 2 ± 24% 0.989 “Reactive”b subjects, n = 31 (11%) –27% D3 versus D1 10 ± 28% 10 ± 33% 0 ± 21% 0.585 “Reactive” subjects, n = 14 (39%) –22% Assessment by clinical inspection D2 versus D1 0.0 ± 1.1 –0.2 ± 1.3 –0.2 ± 0.9 0.181 “Reactive” subjects 11 (31%) D3 versus D1 –0.2 ± 1.2% –0.6 ± 1.4% –0.4 ± 0.9% 0.031 “Reactive” subjects 13 (36%) Repair of skin barrier function, % variation TEWL D2 versus D1 14.3 ± 40.7% –9.5 ± 28.7 –23.8 ± 29.9 0.001 “Reactive” subjects, n = 26 (72%) 34% D3 versus D1 5.5 ± 36.7% –23.1 ± 29.8% –28.6 ± 28.1% 0.001 “Reactive”subjects, n = 26 (72%) 37.8% Epidermal cell renewal ITA angle, D3 14.9 ± 8.6 14.9 ± 8.6 0.01 ITA angle, D14 39.1 ± 11.8 45.3 ± 6.8 D1, 1 h after removal of the patches and before application of the product D2, after 24 h D3, after 48 h TEWL, transepidermal water loss ITA, individual typological angle. a Student t-test or Mann-Whitney U-test. b “Reactive” subjects D2 versus D1 or D3 versus D1 in treated zone and control zone ≤10% or 0 in case of assessment by clinical inspection. Table II Assessment of the Cosmetic Qualities of the Product (Blastoactiva™) Item of the questionnaire Percentage of subjects who agree or very much agree Has a pleasant texture 94 Leaves the skin feeling soft and smooth 89 Hydrates the skin 83 Has a pleasant smell 83 The product is rapidly absorbed 86 Leaves no residue on the skin 94 Not oily 92 Does not stain clothing 100 It has satisfied me 83 It is a unisex product 100
Purchased for the exclusive use of nofirst nolast (unknown) From: SCC Media Library & Resource Center (library.scconline.org)














































































